SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-18-024806
Filing Date
2018-04-18
Accepted
2018-04-18 13:55:20
Documents
11
Period of Report
2018-06-14
Effectiveness Date
2018-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A a18-7715_3def14a.htm DEF 14A 372801
3 GRAPHIC j1877154_aa001.jpg GRAPHIC 6315
4 GRAPHIC g77153bui001.jpg GRAPHIC 2416
5 GRAPHIC g77153bui002.jpg GRAPHIC 1706
6 GRAPHIC g77153bui003.jpg GRAPHIC 1649
7 GRAPHIC g77153bui004.jpg GRAPHIC 2031
8 GRAPHIC g77153bui005.gif GRAPHIC 78
9 GRAPHIC g77153bui006.gif GRAPHIC 583
10 GRAPHIC g77153bgi001.gif GRAPHIC 1347
11 GRAPHIC g77153bgi002.gif GRAPHIC 199
12 GRAPHIC g77153bci001.gif GRAPHIC 2224
  Complete submission text file 0001104659-18-024806.txt   400892
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Filer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 811-06565 | Film No.: 18760839